Home > > > Report Detail

Global Antisense & RNAi Therapeutics Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

Publisher Name :
Date: 08-Jan-2019
No. of pages: 152

Antisense therapy is a form of treatment for genetic disorders or infections. When the genetic sequence of a particular gene is known to be causative of a particular disease, it is possible to synthesize a strand of nucleic acid (DNA, RNA or a chemical analogue) that will bind to the messenger RNA (mRNA) produced by that gene and inactivate it, effectively turning that gene "off".

Scope of the Report:

This report studies the Antisense & RNAi Therapeutics market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Antisense & RNAi Therapeutics market by product type and applications/end industries.

North America is a key market, with U.S. reflecting a number of RNAi therapeutics currently in developmental pipelines. A number of biotechnology companies have made considerably high investments for RNAi therapeutic development. Big pharmaceutical developers have entered into collaboration agreements or licensing deals with a number of smaller firms in an attempt to capitalize on the expected revenue growth of this market.

The global Antisense & RNAi Therapeutics market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.

The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Antisense & RNAi Therapeutics.

Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.

Market Segment by Companies, this report covers

- Glaxo Smith Kline

- Sanofi Aventis / Genzyme

- Isis Pharmaceuticals/ Ionis Pharmaceuticals

- Arbutus Biopharma Ltd.

- Silence Therapeutics

- Bio-Path Holdings Inc.

- Calando Pharmaceuticals

- ICo Therapeutics

- Quark Pharmaceuticals

- Rexhan Pharmaceuticals

- Biomarin/Prosensa

- Regulus Therapeutics

- Rxi Pharmaceuticals

- Silenseed

- Dicerna Pharmaceuticals

- Sirnaomics Inc.

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

- RNA interference

- SiRNA

- MiRNA

- Antisense RNA

Market Segment by Applications, can be divided into

- Oncology

- Cardiovascular

- Renal

- Neurodegenerative

- Respiratory

- Genetic

- Infectious Diseases

Global Antisense & RNAi Therapeutics Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

Table of Contents

1 Antisense & RNAi Therapeutics Market Overview
1.1 Product Overview and Scope of Antisense & RNAi Therapeutics
1.2 Classification of Antisense & RNAi Therapeutics by Types
1.2.1 Global Antisense & RNAi Therapeutics Revenue Comparison by Types (2017-2023)
1.2.2 Global Antisense & RNAi Therapeutics Revenue Market Share by Types in 2017
1.2.3 RNA interference
1.2.4 SiRNA
1.2.5 MiRNA
1.2.6 Antisense RNA
1.3 Global Antisense & RNAi Therapeutics Market by Application
1.3.1 Global Antisense & RNAi Therapeutics Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Oncology
1.3.3 Cardiovascular
1.3.4 Renal
1.3.5 Neurodegenerative
1.3.6 Respiratory
1.3.7 Genetic
1.3.8 Infectious Diseases
1.4 Global Antisense & RNAi Therapeutics Market by Regions
1.4.1 Global Antisense & RNAi Therapeutics Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Antisense & RNAi Therapeutics Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Antisense & RNAi Therapeutics Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Antisense & RNAi Therapeutics Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Antisense & RNAi Therapeutics Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Antisense & RNAi Therapeutics Status and Prospect (2013-2023)
1.5 Global Market Size of Antisense & RNAi Therapeutics (2013-2023)
2 Manufacturers Profiles
2.1 Glaxo Smith Kline
2.1.1 Business Overview
2.1.2 Antisense & RNAi Therapeutics Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Glaxo Smith Kline Antisense & RNAi Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
2.2 Sanofi Aventis / Genzyme
2.2.1 Business Overview
2.2.2 Antisense & RNAi Therapeutics Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Sanofi Aventis / Genzyme Antisense & RNAi Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
2.3 Isis Pharmaceuticals/ Ionis Pharmaceuticals
2.3.1 Business Overview
2.3.2 Antisense & RNAi Therapeutics Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Isis Pharmaceuticals/ Ionis Pharmaceuticals Antisense & RNAi Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
2.4 Arbutus Biopharma Ltd.
2.4.1 Business Overview
2.4.2 Antisense & RNAi Therapeutics Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Arbutus Biopharma Ltd. Antisense & RNAi Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
2.5 Silence Therapeutics
2.5.1 Business Overview
2.5.2 Antisense & RNAi Therapeutics Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Silence Therapeutics Antisense & RNAi Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
2.6 Bio-Path Holdings Inc.
2.6.1 Business Overview
2.6.2 Antisense & RNAi Therapeutics Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Bio-Path Holdings Inc. Antisense & RNAi Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
2.7 Calando Pharmaceuticals
2.7.1 Business Overview
2.7.2 Antisense & RNAi Therapeutics Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Calando Pharmaceuticals Antisense & RNAi Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
2.8 ICo Therapeutics
2.8.1 Business Overview
2.8.2 Antisense & RNAi Therapeutics Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 ICo Therapeutics Antisense & RNAi Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
2.9 Quark Pharmaceuticals
2.9.1 Business Overview
2.9.2 Antisense & RNAi Therapeutics Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Quark Pharmaceuticals Antisense & RNAi Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
2.10 Rexhan Pharmaceuticals
2.10.1 Business Overview
2.10.2 Antisense & RNAi Therapeutics Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Rexhan Pharmaceuticals Antisense & RNAi Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
2.11 Biomarin/Prosensa
2.11.1 Business Overview
2.11.2 Antisense & RNAi Therapeutics Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Biomarin/Prosensa Antisense & RNAi Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
2.12 Regulus Therapeutics
2.12.1 Business Overview
2.12.2 Antisense & RNAi Therapeutics Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Regulus Therapeutics Antisense & RNAi Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
2.13 Rxi Pharmaceuticals
2.13.1 Business Overview
2.13.2 Antisense & RNAi Therapeutics Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 Rxi Pharmaceuticals Antisense & RNAi Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
2.14 Silenseed
2.14.1 Business Overview
2.14.2 Antisense & RNAi Therapeutics Type and Applications
2.14.2.1 Product A
2.14.2.2 Product B
2.14.3 Silenseed Antisense & RNAi Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
2.15 Dicerna Pharmaceuticals
2.15.1 Business Overview
2.15.2 Antisense & RNAi Therapeutics Type and Applications
2.15.2.1 Product A
2.15.2.2 Product B
2.15.3 Dicerna Pharmaceuticals Antisense & RNAi Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
2.16 Sirnaomics Inc.
2.16.1 Business Overview
2.16.2 Antisense & RNAi Therapeutics Type and Applications
2.16.2.1 Product A
2.16.2.2 Product B
2.16.3 Sirnaomics Inc. Antisense & RNAi Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
3 Global Antisense & RNAi Therapeutics Market Competition, by Players
3.1 Global Antisense & RNAi Therapeutics Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 Antisense & RNAi Therapeutics Players Market Share
3.2.2 Top 10 Antisense & RNAi Therapeutics Players Market Share
3.3 Market Competition Trend
4 Global Antisense & RNAi Therapeutics Market Size by Regions
4.1 Global Antisense & RNAi Therapeutics Revenue and Market Share by Regions
4.2 North America Antisense & RNAi Therapeutics Revenue and Growth Rate (2013-2018)
4.3 Europe Antisense & RNAi Therapeutics Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Antisense & RNAi Therapeutics Revenue and Growth Rate (2013-2018)
4.5 South America Antisense & RNAi Therapeutics Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Antisense & RNAi Therapeutics Revenue and Growth Rate (2013-2018)
5 North America Antisense & RNAi Therapeutics Revenue by Countries
5.1 North America Antisense & RNAi Therapeutics Revenue by Countries (2013-2018)
5.2 USA Antisense & RNAi Therapeutics Revenue and Growth Rate (2013-2018)
5.3 Canada Antisense & RNAi Therapeutics Revenue and Growth Rate (2013-2018)
5.4 Mexico Antisense & RNAi Therapeutics Revenue and Growth Rate (2013-2018)
6 Europe Antisense & RNAi Therapeutics Revenue by Countries
6.1 Europe Antisense & RNAi Therapeutics Revenue by Countries (2013-2018)
6.2 Germany Antisense & RNAi Therapeutics Revenue and Growth Rate (2013-2018)
6.3 UK Antisense & RNAi Therapeutics Revenue and Growth Rate (2013-2018)
6.4 France Antisense & RNAi Therapeutics Revenue and Growth Rate (2013-2018)
6.5 Russia Antisense & RNAi Therapeutics Revenue and Growth Rate (2013-2018)
6.6 Italy Antisense & RNAi Therapeutics Revenue and Growth Rate (2013-2018)
7 Asia-Pacific Antisense & RNAi Therapeutics Revenue by Countries
7.1 Asia-Pacific Antisense & RNAi Therapeutics Revenue by Countries (2013-2018)
7.2 China Antisense & RNAi Therapeutics Revenue and Growth Rate (2013-2018)
7.3 Japan Antisense & RNAi Therapeutics Revenue and Growth Rate (2013-2018)
7.4 Korea Antisense & RNAi Therapeutics Revenue and Growth Rate (2013-2018)
7.5 India Antisense & RNAi Therapeutics Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Antisense & RNAi Therapeutics Revenue and Growth Rate (2013-2018)
8 South America Antisense & RNAi Therapeutics Revenue by Countries
8.1 South America Antisense & RNAi Therapeutics Revenue by Countries (2013-2018)
8.2 Brazil Antisense & RNAi Therapeutics Revenue and Growth Rate (2013-2018)
8.3 Argentina Antisense & RNAi Therapeutics Revenue and Growth Rate (2013-2018)
8.4 Colombia Antisense & RNAi Therapeutics Revenue and Growth Rate (2013-2018)
9 Middle East and Africa Revenue Antisense & RNAi Therapeutics by Countries
9.1 Middle East and Africa Antisense & RNAi Therapeutics Revenue by Countries (2013-2018)
9.2 Saudi Arabia Antisense & RNAi Therapeutics Revenue and Growth Rate (2013-2018)
9.3 UAE Antisense & RNAi Therapeutics Revenue and Growth Rate (2013-2018)
9.4 Egypt Antisense & RNAi Therapeutics Revenue and Growth Rate (2013-2018)
9.5 Nigeria Antisense & RNAi Therapeutics Revenue and Growth Rate (2013-2018)
9.6 South Africa Antisense & RNAi Therapeutics Revenue and Growth Rate (2013-2018)
10 Global Antisense & RNAi Therapeutics Market Segment by Type
10.1 Global Antisense & RNAi Therapeutics Revenue and Market Share by Type (2013-2018)
10.2 Global Antisense & RNAi Therapeutics Market Forecast by Type (2018-2023)
10.3 RNA interference Revenue Growth Rate (2013-2023)
10.4 SiRNA Revenue Growth Rate (2013-2023)
10.5 MiRNA Revenue Growth Rate (2013-2023)
10.6 Antisense RNA Revenue Growth Rate (2013-2023)
11 Global Antisense & RNAi Therapeutics Market Segment by Application
11.1 Global Antisense & RNAi Therapeutics Revenue Market Share by Application (2013-2018)
11.2 Antisense & RNAi Therapeutics Market Forecast by Application (2018-2023)
11.3 Oncology Revenue Growth (2013-2018)
11.4 Cardiovascular Revenue Growth (2013-2018)
11.5 Renal Revenue Growth (2013-2018)
11.6 Neurodegenerative Revenue Growth (2013-2018)
11.7 Respiratory Revenue Growth (2013-2018)
11.8 Genetic Revenue Growth (2013-2018)
11.9 Infectious Diseases Revenue Growth (2013-2018)
12 Global Antisense & RNAi Therapeutics Market Size Forecast (2018-2023)
12.1 Global Antisense & RNAi Therapeutics Market Size Forecast (2018-2023)
12.2 Global Antisense & RNAi Therapeutics Market Forecast by Regions (2018-2023)
12.3 North America Antisense & RNAi Therapeutics Revenue Market Forecast (2018-2023)
12.4 Europe Antisense & RNAi Therapeutics Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Antisense & RNAi Therapeutics Revenue Market Forecast (2018-2023)
12.6 South America Antisense & RNAi Therapeutics Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Antisense & RNAi Therapeutics Revenue Market Forecast (2018-2023)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source

List of Tables and Figures

Figure Antisense & RNAi Therapeutics Picture
Table Product Specifications of Antisense & RNAi Therapeutics
Table Global Antisense & RNAi Therapeutics and Revenue (Million USD) Market Split by Product Type
Figure Global Antisense & RNAi Therapeutics Revenue Market Share by Types in 2017
Figure RNA interference Picture
Figure SiRNA Picture
Figure MiRNA Picture
Figure Antisense RNA Picture
Table Global Antisense & RNAi Therapeutics Revenue (Million USD) by Application (2013-2023)
Figure Antisense & RNAi Therapeutics Revenue Market Share by Applications in 2017
Figure Oncology Picture
Figure Cardiovascular Picture
Figure Renal Picture
Figure Neurodegenerative Picture
Figure Respiratory Picture
Figure Genetic Picture
Figure Infectious Diseases Picture
Table Global Market Antisense & RNAi Therapeutics Revenue (Million USD) Comparison by Regions 2013-2023
Figure North America Antisense & RNAi Therapeutics Revenue (Million USD) and Growth Rate (2013-2023)
Figure Europe Antisense & RNAi Therapeutics Revenue (Million USD) and Growth Rate (2013-2023)
Figure Asia-Pacific Antisense & RNAi Therapeutics Revenue (Million USD) and Growth Rate (2013-2023)
Figure South America Antisense & RNAi Therapeutics Revenue (Million USD) and Growth Rate (2013-2023)
Figure Middle East and Africa Antisense & RNAi Therapeutics Revenue (Million USD) and Growth Rate (2013-2023)
Figure Global Antisense & RNAi Therapeutics Revenue (Million USD) and Growth Rate (2013-2023)
Table Glaxo Smith Kline Basic Information, Manufacturing Base and Competitors
Table Glaxo Smith Kline Antisense & RNAi Therapeutics Type and Applications
Table Glaxo Smith Kline Antisense & RNAi Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
Table Sanofi Aventis / Genzyme Basic Information, Manufacturing Base and Competitors
Table Sanofi Aventis / Genzyme Antisense & RNAi Therapeutics Type and Applications
Table Sanofi Aventis / Genzyme Antisense & RNAi Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
Table Isis Pharmaceuticals/ Ionis Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Isis Pharmaceuticals/ Ionis Pharmaceuticals Antisense & RNAi Therapeutics Type and Applications
Table Isis Pharmaceuticals/ Ionis Pharmaceuticals Antisense & RNAi Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
Table Arbutus Biopharma Ltd. Basic Information, Manufacturing Base and Competitors
Table Arbutus Biopharma Ltd. Antisense & RNAi Therapeutics Type and Applications
Table Arbutus Biopharma Ltd. Antisense & RNAi Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
Table Silence Therapeutics Basic Information, Manufacturing Base and Competitors
Table Silence Therapeutics Antisense & RNAi Therapeutics Type and Applications
Table Silence Therapeutics Antisense & RNAi Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
Table Bio-Path Holdings Inc. Basic Information, Manufacturing Base and Competitors
Table Bio-Path Holdings Inc. Antisense & RNAi Therapeutics Type and Applications
Table Bio-Path Holdings Inc. Antisense & RNAi Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
Table Calando Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Calando Pharmaceuticals Antisense & RNAi Therapeutics Type and Applications
Table Calando Pharmaceuticals Antisense & RNAi Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
Table ICo Therapeutics Basic Information, Manufacturing Base and Competitors
Table ICo Therapeutics Antisense & RNAi Therapeutics Type and Applications
Table ICo Therapeutics Antisense & RNAi Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
Table Quark Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Quark Pharmaceuticals Antisense & RNAi Therapeutics Type and Applications
Table Quark Pharmaceuticals Antisense & RNAi Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
Table Rexhan Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Rexhan Pharmaceuticals Antisense & RNAi Therapeutics Type and Applications
Table Rexhan Pharmaceuticals Antisense & RNAi Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
Table Biomarin/Prosensa Basic Information, Manufacturing Base and Competitors
Table Biomarin/Prosensa Antisense & RNAi Therapeutics Type and Applications
Table Biomarin/Prosensa Antisense & RNAi Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
Table Regulus Therapeutics Basic Information, Manufacturing Base and Competitors
Table Regulus Therapeutics Antisense & RNAi Therapeutics Type and Applications
Table Regulus Therapeutics Antisense & RNAi Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
Table Rxi Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Rxi Pharmaceuticals Antisense & RNAi Therapeutics Type and Applications
Table Rxi Pharmaceuticals Antisense & RNAi Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
Table Silenseed Basic Information, Manufacturing Base and Competitors
Table Silenseed Antisense & RNAi Therapeutics Type and Applications
Table Silenseed Antisense & RNAi Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
Table Dicerna Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Dicerna Pharmaceuticals Antisense & RNAi Therapeutics Type and Applications
Table Dicerna Pharmaceuticals Antisense & RNAi Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
Table Sirnaomics Inc. Basic Information, Manufacturing Base and Competitors
Table Sirnaomics Inc. Antisense & RNAi Therapeutics Type and Applications
Table Sirnaomics Inc. Antisense & RNAi Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
Table Global Antisense & RNAi Therapeutics Revenue (Million USD) by Players (2013-2018)
Table Global Antisense & RNAi Therapeutics Revenue Share by Players (2013-2018)
Figure Global Antisense & RNAi Therapeutics Revenue Share by Players in 2016
Figure Global Antisense & RNAi Therapeutics Revenue Share by Players in 2017
Figure Global Top 5 Players Antisense & RNAi Therapeutics Revenue Market Share in 2017
Figure Global Top 10 Players Antisense & RNAi Therapeutics Revenue Market Share in 2017
Figure Global Antisense & RNAi Therapeutics Revenue (Million USD) and Growth Rate (%) (2013-2018)
Table Global Antisense & RNAi Therapeutics Revenue (Million USD) by Regions (2013-2018)
Table Global Antisense & RNAi Therapeutics Revenue Market Share by Regions (2013-2018)
Figure Global Antisense & RNAi Therapeutics Revenue Market Share by Regions (2013-2018)
Figure Global Antisense & RNAi Therapeutics Revenue Market Share by Regions in 2017
Figure North America Antisense & RNAi Therapeutics Revenue and Growth Rate (2013-2018)
Figure Europe Antisense & RNAi Therapeutics Revenue and Growth Rate (2013-2018)
Figure Asia-Pacific Antisense & RNAi Therapeutics Revenue and Growth Rate (2013-2018)
Figure South America Antisense & RNAi Therapeutics Revenue and Growth Rate (2013-2018)
Figure Middle East and Africa Antisense & RNAi Therapeutics Revenue and Growth Rate (2013-2018)
Table North America Antisense & RNAi Therapeutics Revenue by Countries (2013-2018)
Table North America Antisense & RNAi Therapeutics Revenue Market Share by Countries (2013-2018)
Figure North America Antisense & RNAi Therapeutics Revenue Market Share by Countries (2013-2018)
Figure North America Antisense & RNAi Therapeutics Revenue Market Share by Countries in 2017
Figure USA Antisense & RNAi Therapeutics Revenue and Growth Rate (2013-2018)
Figure Canada Antisense & RNAi Therapeutics Revenue and Growth Rate (2013-2018)
Figure Mexico Antisense & RNAi Therapeutics Revenue and Growth Rate (2013-2018)
Table Europe Antisense & RNAi Therapeutics Revenue (Million USD) by Countries (2013-2018)
Figure Europe Antisense & RNAi Therapeutics Revenue Market Share by Countries (2013-2018)
Figure Europe Antisense & RNAi Therapeutics Revenue Market Share by Countries in 2017
Figure Germany Antisense & RNAi Therapeutics Revenue and Growth Rate (2013-2018)
Figure UK Antisense & RNAi Therapeutics Revenue and Growth Rate (2013-2018)
Figure France Antisense & RNAi Therapeutics Revenue and Growth Rate (2013-2018)
Figure Russia Antisense & RNAi Therapeutics Revenue and Growth Rate (2013-2018)
Figure Italy Antisense & RNAi Therapeutics Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Antisense & RNAi Therapeutics Revenue (Million USD) by Countries (2013-2018)
Figure Asia-Pacific Antisense & RNAi Therapeutics Revenue Market Share by Countries (2013-2018)
Figure Asia-Pacific Antisense & RNAi Therapeutics Revenue Market Share by Countries in 2017
Figure China Antisense & RNAi Therapeutics Revenue and Growth Rate (2013-2018)
Figure Japan Antisense & RNAi Therapeutics Revenue and Growth Rate (2013-2018)
Figure Korea Antisense & RNAi Therapeutics Revenue and Growth Rate (2013-2018)
Figure India Antisense & RNAi Therapeutics Revenue and Growth Rate (2013-2018)
Figure Southeast Asia Antisense & RNAi Therapeutics Revenue and Growth Rate (2013-2018)
Table South America Antisense & RNAi Therapeutics Revenue by Countries (2013-2018)
Table South America Antisense & RNAi Therapeutics Revenue Market Share by Countries (2013-2018)
Figure South America Antisense & RNAi Therapeutics Revenue Market Share by Countries (2013-2018)
Figure South America Antisense & RNAi Therapeutics Revenue Market Share by Countries in 2017
Figure Brazil Antisense & RNAi Therapeutics Revenue and Growth Rate (2013-2018)
Figure Argentina Antisense & RNAi Therapeutics Revenue and Growth Rate (2013-2018)
Figure Colombia Antisense & RNAi Therapeutics Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Antisense & RNAi Therapeutics Revenue (Million USD) by Countries (2013-2018)
Table Middle East and Africa Antisense & RNAi Therapeutics Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Antisense & RNAi Therapeutics Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Antisense & RNAi Therapeutics Revenue Market Share by Countries in 2017
Figure Saudi Arabia Antisense & RNAi Therapeutics Revenue and Growth Rate (2013-2018)
Figure UAE Antisense & RNAi Therapeutics Revenue and Growth Rate (2013-2018)
Figure Egypt Antisense & RNAi Therapeutics Revenue and Growth Rate (2013-2018)
Figure Nigeria Antisense & RNAi Therapeutics Revenue and Growth Rate (2013-2018)
Figure South Africa Antisense & RNAi Therapeutics Revenue and Growth Rate (2013-2018)
Table Global Antisense & RNAi Therapeutics Revenue (Million USD) by Type (2013-2018)
Table Global Antisense & RNAi Therapeutics Revenue Share by Type (2013-2018)
Figure Global Antisense & RNAi Therapeutics Revenue Share by Type (2013-2018)
Figure Global Antisense & RNAi Therapeutics Revenue Share by Type in 2017
Table Global Antisense & RNAi Therapeutics Revenue Forecast by Type (2018-2023)
Figure Global Antisense & RNAi Therapeutics Market Share Forecast by Type (2018-2023)
Figure Global RNA interference Revenue Growth Rate (2013-2018)
Figure Global SiRNA Revenue Growth Rate (2013-2018)
Figure Global MiRNA Revenue Growth Rate (2013-2018)
Figure Global Antisense RNA Revenue Growth Rate (2013-2018)
Table Global Antisense & RNAi Therapeutics Revenue by Application (2013-2018)
Table Global Antisense & RNAi Therapeutics Revenue Share by Application (2013-2018)
Figure Global Antisense & RNAi Therapeutics Revenue Share by Application (2013-2018)
Figure Global Antisense & RNAi Therapeutics Revenue Share by Application in 2017
Table Global Antisense & RNAi Therapeutics Revenue Forecast by Application (2018-2023)
Figure Global Antisense & RNAi Therapeutics Market Share Forecast by Application (2018-2023)
Figure Global Oncology Revenue Growth Rate (2013-2018)
Figure Global Cardiovascular Revenue Growth Rate (2013-2018)
Figure Global Renal Revenue Growth Rate (2013-2018)
Figure Global Neurodegenerative Revenue Growth Rate (2013-2018)
Figure Global Respiratory Revenue Growth Rate (2013-2018)
Figure Global Genetic Revenue Growth Rate (2013-2018)
Figure Global Infectious Diseases Revenue Growth Rate (2013-2018)
Figure Global Antisense & RNAi Therapeutics Revenue (Million USD) and Growth Rate Forecast (2018 -2023)
Table Global Antisense & RNAi Therapeutics Revenue (Million USD) Forecast by Regions (2018-2023)
Figure Global Antisense & RNAi Therapeutics Revenue Market Share Forecast by Regions (2018-2023)
Figure North America Antisense & RNAi Therapeutics Revenue Market Forecast (2018-2023)
Figure Europe Antisense & RNAi Therapeutics Revenue Market Forecast (2018-2023)
Figure Asia-Pacific Antisense & RNAi Therapeutics Revenue Market Forecast (2018-2023)
Figure South America Antisense & RNAi Therapeutics Revenue Market Forecast (2018-2023)
Figure Middle East and Africa Antisense & RNAi Therapeutics Revenue Market Forecast (2018-2023)
  • Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029
    Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118
    The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......
  • Global Non-imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95
    The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90
    The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......
  • Global PCR Equipment Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77
    The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......
  • Global Disposable Sterile Syringes and Needles Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109
    The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......
  • Global Orthopaedic Power Tools Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......
  • Global Cerebrospinal Fluid Management Devices Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......
  • Global CAD & CAM Milling Burs Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79
    The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......
  • Global Artificial Teeth Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98
    The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs